As of Sep 23
| -0.0027 / -0.38%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 1.25, with a high estimate of 10.00 and a low estimate of 1.00. The median estimate represents a +77.99% increase from the last price of 0.70.
The current consensus among 3 polled investment analysts is to Hold stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since September, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.